Amidate(tm) Etomidate Injection, Solution
Product Images NDC 51662-1459

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Amidate(tm) Etomidate (NDC 51662-1459). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Alternate Vial Label 1 (1459 1 Alternate Vial Label 1)

Amidate (Etomidate Injection, USP) 2 mg/mL intravenous injection solution in a 10 mL single-dose fliptop vial. The label includes dosage strength 20 mg/10 mL, manufacturer Hospira, Inc., and space for lot number and expiration date. The label specifies Rx only and sterile, nonpyrogenic contents with propylene glycol.*

FDA Label Image

Serialized Vial Labeling (1459 1 Serialized Vial Labeling)

AMIDATE™ Etomidate Injection, USP 2 mg/mL in a 10 mL single-dose Fliptoph vial. The label indicates the product is for intravenous use only, distributed by HF Acquisition Co LLC, DBA HealthFirst. The vial has a blue flip-top cap and includes a barcode and regulatory information on the label.*

FDA Label Image

Surerseeded Vial Label (1459 1 Superseeded Vial Label)

Label for Amidate Etomidate Injection USP, 2 mg/mL strength, presenting a 10 mL single-dose fliptop vial. The label indicates intravenous use only and lists Hospira, Inc. as the manufacturer. It includes the NDC 0409-6695-01 and states each mL contains 2 mg etomidate and 35% propylene glycol, sterile and nonpyrogenic.*

FDA Label Image

Vial Label (1459 1 Vial Label)

Label of Amidate Etomidate Injection USP 20 mg/10 mL (2 mg/mL) single-dose fliptop vial for intravenous use. The label includes dosage strength, active ingredient etomidate, NDC 0409-6695-11, bar code, and distributor Hospira, Inc. address.*

FDA Label Image

Alternate Vial Label 2 (Alternate Vial Label 2)

Label for Amidate (Etomidate Injection, USP) 20 mg/10 mL (2 mg/mL) single-dose fliptop vial. It is for intravenous use only. The label notes the product is sterile and nonpyrogenic, with each mL containing 2 mg etomidate and 35% propylene glycol. Distributed by Hospira, Inc., Lake Forest, IL.*

FDA Label Image

How Supplied (How Supplied)

A data table showing units of sale and concentrations for a product with 2 mg/mL concentration. It lists three packaging options: trays of 10 fliptop vials with NDCs 0409-6695-01 (20 mg/10 mL) and 0409-6695-02 (40 mg/20 mL), and a bundle of 10 Abboject syringes (20 mL with male luer lock adapter) with NDC 0409-8060-29 (40 mg/20 mL).*

FDA Label Image

Logo (Logo)

FDA Label Image

Structure (Structure)

Chemical structure of AMIDATE(TM) ETOMIDATE, showing a molecular diagram with characteristic rings and bonds representing the etomidate molecule.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.